Table 1 Clinicopathological table
No. | Cell line | Sex | Age | Derived origin | Growth pattern | Doubling time | Cell morphology | Clinical stage | First treatment | Chemotherapy regimen (RESPONSE) | Surgery |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | SNU-2729B1 | M | 46 | Tissue | Adherent | 50.4 | Polygonal | Metastatic | Chemotherapy | Gemcitabine/Erlotinib (Progressive disease) | Not applicable |
2 | SNU-2822 | F | 68 | Ascites | Adherent | 60.7 | Fibroblast-like | Metastatic | Chemotherapy | Gemcitabine/Cisplatin (Stable disease) | Not applicable |
3 | SNU-2913 | M | 55 | Ascites | Adherent | 22.6 | Fibroblast-like/Polygonal | Metastatic | Chemotherapy | FOLFIRINOX (Progressive disease) | Not applicable |
4 | SNU-2918 | F | 61 | Ascites | Adherent | 75 | Oval | Resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
5 | SNU-2982-1 | F | 71 | Ascites | Adherent | 66 | Polygonal | Locally advanced | Chemotherapy | FOLFIRINOX (Stable disease) | Not applicable |
6 | SNU-3139 | M | 78 | Tissue | Adherent | 77.2 | Polygonal | Locally advanced | Chemotherapy | 5-fluorouracil (Stable disease) | Not applicable |
7 | SNU-3294 | M | 66 | Tissue | Adherent | 85.4 | Polygonal | Borderline resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
8 | SNU-3375 | M | 55 | Tissue | Adherent | 52.3 | Round | Resectable | Surgery | Not applicable | Distal pancreatectomy |
9 | SNU-3573 | M | 49 | Tissue | Adherent | 67.6 | Polygonal | Metastatic | Chemotherapy | FOLFIRINOX (Partial response) | Not applicable |
10 | SNU-3608 | M | 76 | Tissue | Adherent | 59.5 | Polygonal | Resectable | Surgery | Not applicable | Distal pancreatectomy |
11 | SNU-3615 | M | 77 | Tissue | Adherent | 68.4 | Oval/Round | Resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
12 | SNU-3752 | F | 70 | Tissue | Adherent | 113 | Polygonal/Round | Resectable | Surgery | Not applicable | Distal pancreatectomy |
13 | SNU-3923T* | M | 69 | Tissue | Adherent | 80.4 | Round | Resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
14 | SNU-4208T* | M | 45 | Biopsy | Adherent | 61.9 | Round | Metastatic | Chemotherapy | FOLFIRINOX (Progressive disease) | Not applicable |
15 | SNU-4223 | F | 47 | Tissue | Adherent | 79.3 | Polygonal | Borderline resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
16 | SNU-4305T* | F | 59 | Biopsy | Adherent | 45.1 | Polygonal | Locally advanced | Chemotherapy | FOLFIRINOX (Stable disease) | Not applicable |
17 | SNU-4340T* | M | 66 | Biopsy | Adherent | 85.1 | Polygonal | Metastatic | Chemotherapy | FOLFIRINOX (Stable disease) | Not applicable |
18 | SNU-4354T* | F | 64 | Biopsy | Adherent | 73.2 | Polygonal | Locally advanced | Chemotherapy | FOLFIRINOX (Progressive disease) | Not applicable |
19 | SNU-4405 | F | 61 | Tissue | Adherent | 119.5 | Polygonal | Resectable | Surgery | Not applicable | Distal pancreatectomy |
20 | SNU-4482 | M | 65 | Tissue | Adherent | 48.6 | Polygonal | Resectable | Surgery | Not applicable | Total pancreatectomy |
21 | SNU-4492 | F | 80 | Tissue | Adherent | 37.9 | Oval/Round | Resectable | Surgery | Not applicable | Distal pancreatectomy |
22 | SNU-4525 | M | 56 | Tissue | Adherent | 78.2 | Oval | Resectable | Surgery | Not applicable | Distal pancreatectomy |
23 | SNU-4733 | M | 61 | Tissue | Adherent | 63.8 | Polygonal | Resectable | Surgery | Not applicable | Distal pancreatectomy |
24 | SNU-4771 | M | 73 | Tissue | Adherent | 48.3 | Polygonal | Resectable | Chemotherapy | FOLFIRINOX (Partial response) | Not applicable |
25 | SNU-4866 | M | 67 | Tissue | Adherent | 85.7 | Polygonal | Resectable | Surgery | Not applicable | Pancreaticoduodenectomy |
26 | SNU-5177 | F | 57 | Tissue | Adherent | 92.3 | Polygonal | Borderline resectable | Chemotherapy | FOLFIRINOX (Partial response) | Not applicable |